path population assessment of tobacco and health

path population assessment of tobacco and health FDA Grand Rounds - The from Data to Action: Key Findings from the (PATH) Study to Inform FDA's Regulatory Activities - 01/16/2025 FDA: New PATH Study Data

Name: path population assessment of tobacco and health FDA Grand Rounds - The from Data to Action: Key Findings from the (PATH) Study to Inform FDA's Regulatory Activities - 01/16/2025 FDA: New PATH Study Data
Brand: trustt.digital
SKU: 21256784509
Price: 27.51 USD
Availability: InStock
Rating: 4.8676 (16 reviews)

FDA: New PATH Study Data Files Available for Researchers Tobacco Reporter Design and methods of the Population Assessment of Tobacco and Health (PATH) Study Tobacco Control Patterns of poly tobacco use among adults in the Population Assessment of Tobacco and Health (PATH) study, 20132017: a multistate Markov transition analysis Tobacco Control Perceptions of nicotine harm among adults who use little cigars and cigarillos: A cross sectional analysis of wave 7 of the Population Assessment of Tobacco and Health (PATH) Study 20222023

SKU: 21256784509 · From trustt.digital

4.9

USD27.51 USD70.51

Pay in 4 interest-free payments of $6.88 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

While the causes can vary, ranging from genetic factors to autoimmune disorders, research has consistently pointed to smoking as a major risk factor for the early onset of menopause

path population assessment of tobacco and health FDA Grand Rounds - The from Data to Action: Key Findings from the (PATH) Study to Inform FDA's Regulatory Activities - 01/16/2025 FDA: New PATH Study Data

The resulting residual confounding suggests that the apparent association between EC use and health outcomes could in reality be partly, or perhaps fully, explained by cumulative smoking history